Filing Details
- Accession Number:
- 0000059478-24-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 16:27:13
- Reporting Period:
- 2024-02-12
- Accepted Time:
- 2024-03-11 16:27:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Eli Lilly & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1561539 | A Donald Zakrowski | Lilly Corporate Center Indianapolis IN 46285 | Svp, Finance, & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-03-11 | 750 | $753.60 | 7,880 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2024-02-12 | 184 | $0.00 | 184 | $0.00 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2024-02-12 | 186 | $0.00 | 186 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 184 | 2026-02-16 | 2026-02-16 | No | 4 | A | Direct |
| 186 | 2027-02-16 | 2027-02-16 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,710 | Indirect | 401(k) |
Footnotes
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
- Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024.
Billionaire Hedge Funds
